Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
uniQure N.V.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
259 institutional managers report a position in uniQure N.V. worth $3.6B between them, filed on form 13F for the quarter ending 2026-06-30. 39 of them hold 80% of it, the largest being venBio Select Advisor LLC at 8.69%.
234 more managers in the register
39 managers hold 80% of the $3.6B institutional base. The other 220 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
QURE (uniQure N.V.) has 9 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via venBio Select Advisor LLC, RTW Investments, LLC, MPM Oncology Impact Management LP +5 more · 8.69% of QURE, 7.95% of TSHA
via venBio Select Advisor LLC, RTW Investments, LLC, Caption Management, LLC +7 more · 8.69% of QURE, 7.63% of MDGL
via venBio Select Advisor LLC, RTW Investments, LLC, Caption Management, LLC +9 more · 8.69% of QURE, 5.81% of CELC
via venBio Select Advisor LLC, RTW Investments, LLC, Orbimed Advisors LLC +4 more · 8.69% of QURE, 9.62% of GPCR
via venBio Select Advisor LLC, Boxer Capital Management, LLC, Balyasny Asset Management LLC +4 more · 8.69% of QURE, 10.26% of FTH
via venBio Select Advisor LLC, Orbimed Advisors LLC, Caption Management, LLC +10 more · 8.69% of QURE, 5.66% of XENE
Managers holding a meaningful stake in QURE also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.